Rel B, son humain étiqueté, recombinant, exprimé en cellules du baculovirus infectées par le Sf9, > = 70 % (SDS-PAGE),solution aqueuse tamponnée de glycérol

Code: srp5125-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Rel B is part of the NFκB complex and forms heterodimeric complexes with p50 (NFKB1) and p52 (NFKB2). The homodimeric complexes of Rel B alone do not...


en savoir plus

Votre prix
£296.00 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Rel B is part of the NFκB complex and forms heterodimeric complexes with p50 (NFKB1) and p52 (NFKB2). The homodimeric complexes of Rel B alone do not show DNA-binding activity. IHC analysis has shown that Rel B expression correlated with dendritic cell activation. NFκB-inducing kinase NIK is required for osteoclastogenesis in response to pathologic stimuli and overexpression of Rel B rescues differentiation of mouse NIK -/- osteoclast precursors. Rel B is required for RANKL-induced osteoclastogenesis in vitro and for TNF -induced bone resorption in vivo. This indicates that the alternative NFκB pathway, via Rel B, plays an essential and unique role in RANKL signaling toward osteoclast development.

Physical form

Supplied in 50mM sodium phosphate, pH 7.0, 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... RELB(5971)
mol wt~68 kDa
NCBI accession no.NM_006509
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
storage temp.−70°C
Ce produit répond aux critères suivants: